Saliwell Overview
Saliwell has developed the SaliPen, a device for stimulation of natural saliva production to treat dry mouth disease (xerostomia). The SaliPen uses electro-stimulation, which isn't felt by the patient, to increase the production of saliva. Its two flexible arms with stimulating electrodes are placed in the mouth underneath the tongue. The electro-stimulation provided by SaliPen, along with its removable intraoral design, offers a practical and effective approach to address the challenges of dry mouth.
Latest News
growth-positive
Device to make patients' mouths water trialled at GWH (and you can find out about it tonight!)
US firm Saliwell is testing its SaliPen massage device at the Great Western Hospital in Swindon. The device uses electric pulses to stimulate the salivary glands and is designed to help those suffering from Sjögren’s Syndrome. The condition affects around 0.6% of adults in the UK and causes dry mouth, itchy eyes, and dry skin. The SaliPen has a positive impact on patients quality of life, but it needs approval for use on the NHS. The Great Western Hospital is currently involved in 55 clinical trials and offers new treatments to patients. The hospitals research team is funded by the National Institute of Health Research.
Customers
growth-negative
Atia Group shareholders approves Saliwell merger
Atia Group Ltd. shareholders have approved a merger with medical device company Saliwell Ltd. The merger will turn Atia Group into a medical device company with NIS 6 million in cash. The deal was approved with a 63% majority. Saliwell has developed a device for stimulating saliva production to treat dry mouth disease. Dry mouth affects 10% of the population and can lead to sleep disturbance and higher blood pressure.
AcquisitionManagement Changes
growth-positive
A microchip placed in the mouth to improve the life of people that suffer from Xerostomia
SALIWELL, a joint European and Israeli research team, has developed two electronic devices that improve saliva production in patients suffering from Xerostomia. The devices, called GenNarino and SALIWELL Crown, stimulate the production of saliva through electronic stimulation. The GenNarino device can be easily placed and removed from the mouth, while the SALIWELL Crown is a permanently placed stimulating device attached to a dental implant. Both devices have a built-in microprocessor, power source, stimulation electrodes, and moisture sensor. The devices have been tested on patients in Berlin, Madrid, Naples, and Jerusalem, and have shown positive results. Xerostomia affects 10% of the Western population and can lead to dental problems and discomfort. The SALIWELL devices provide a cheap and effective remedy for Xerostomia sufferers.
Customers
growth-positive
Israeli project develops novel solution to dry mouth
Israeli company Saliwell has developed a removable device called the GenNarino that stimulates saliva production through electro-stimulation. The device applies a low energy level of electricity to the nerves associated with salivary glands, resulting in increased saliva secretion. Xerostomia, or dry mouth, is a chronic condition that affects 80 million people in the developed world. It is caused by a lack of lubrication in the mouth and is often a side effect of medication or radiation therapy. Saliwells solution offers a comfortable and side effect-free treatment for xerostomia, providing relief for those who suffer from the condition. The company is also developing the Saliwell Crown, a solution that can be attached to a regular permanent dental implant.
Customers
growth-positive
New devices for people who suffer dry mouth or lack of saliva
Saliwell has developed innovative devices that stimulate saliva production for dry mouth sufferers. Their removable device, GenNarino, is custom made and their Saliwell Crown is attached to a regular permanent dental implant. The devices have undergone clinical trials and have received positive feedback. Saliwell hopes to market the GenNarino next year and merge with a larger company. The company aims to provide a non-chemical solution for dry mouth sufferers.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $2.18M |
| Last funding | $2.18M |
| Stage | Mature |
| Rounds | 1 |
| Investors | 0 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | saliwell.com |
Locations
HaTamar St 3a, Harutzim, Israel
Im Helmerswald 2, 66121 Saarbrcken, Germany
20-22 Wenlock Rd, London N1 7GU, UK
Photos & Videos
4 item(s)
Saliwell Business
Business models
B2C
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersCore Technology
Semiconductors & ElectronicsTags (7)
non-invasivemedical-deviceshome-careneuro-stimulationmedical-technologiespatientsnanotechnologyGeographic Markets
GlobalSaliwell Financials
$2.18M
Total funding
—
Capital raised
$2.18M
Last funding
Mature
Funding stage
1
Total rounds
0
Investors
Non-Equity Funding
GrantEvent
Sep 2006
$2.18M
European Innovation Council
Saliwell Lifecycle
All Events
GrantEvent
Sep 2006
$2.18M
European Innovation Council
Saliwell News
5 articles
growth-positive
Device to make patients' mouths water trialled at GWH (and you can find out about it tonight!)
US firm Saliwell is testing its SaliPen massage device at the Great Western Hospital in Swindon. The device uses electric pulses to stimulate the salivary glands and is designed to help those suffering from Sjögren’s Syndrome. The condition affects around 0.6% of adults in the UK and causes dry mouth, itchy eyes, and dry skin. The SaliPen has a positive impact on patients quality of life, but it needs approval for use on the NHS. The Great Western Hospital is currently involved in 55 clinical trials and offers new treatments to patients. The hospitals research team is funded by the National Institute of Health Research.
Customers
growth-negative
Atia Group shareholders approves Saliwell merger
Atia Group Ltd. shareholders have approved a merger with medical device company Saliwell Ltd. The merger will turn Atia Group into a medical device company with NIS 6 million in cash. The deal was approved with a 63% majority. Saliwell has developed a device for stimulating saliva production to treat dry mouth disease. Dry mouth affects 10% of the population and can lead to sleep disturbance and higher blood pressure.
AcquisitionManagement Changes
growth-positive
A microchip placed in the mouth to improve the life of people that suffer from Xerostomia
SALIWELL, a joint European and Israeli research team, has developed two electronic devices that improve saliva production in patients suffering from Xerostomia. The devices, called GenNarino and SALIWELL Crown, stimulate the production of saliva through electronic stimulation. The GenNarino device can be easily placed and removed from the mouth, while the SALIWELL Crown is a permanently placed stimulating device attached to a dental implant. Both devices have a built-in microprocessor, power source, stimulation electrodes, and moisture sensor. The devices have been tested on patients in Berlin, Madrid, Naples, and Jerusalem, and have shown positive results. Xerostomia affects 10% of the Western population and can lead to dental problems and discomfort. The SALIWELL devices provide a cheap and effective remedy for Xerostomia sufferers.
Customers
growth-positive
Israeli project develops novel solution to dry mouth
Israeli company Saliwell has developed a removable device called the GenNarino that stimulates saliva production through electro-stimulation. The device applies a low energy level of electricity to the nerves associated with salivary glands, resulting in increased saliva secretion. Xerostomia, or dry mouth, is a chronic condition that affects 80 million people in the developed world. It is caused by a lack of lubrication in the mouth and is often a side effect of medication or radiation therapy. Saliwells solution offers a comfortable and side effect-free treatment for xerostomia, providing relief for those who suffer from the condition. The company is also developing the Saliwell Crown, a solution that can be attached to a regular permanent dental implant.
Customers
growth-positive
New devices for people who suffer dry mouth or lack of saliva
Saliwell has developed innovative devices that stimulate saliva production for dry mouth sufferers. Their removable device, GenNarino, is custom made and their Saliwell Crown is attached to a regular permanent dental implant. The devices have undergone clinical trials and have received positive feedback. Saliwell hopes to market the GenNarino next year and merge with a larger company. The company aims to provide a non-chemical solution for dry mouth sufferers.
Customers
Saliwell Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Saliwell Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | funding rounds, markets, not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 513383679 |
| Crunchbase | saliwell |
| Phone | +97235347592 |
| Creator | Tamar Weiss |
| Creator email | tamar.e.weiss@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-01-18T00:00:00.000Z |
| Created | 2014-07-31T00:00:00.000Z |